Status:
COMPLETED
Figure of 8 Walk Test in Multiple Sclerosis
Lead Sponsor:
Kahramanmaras Sutcu Imam University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Brief Summary
Balance disorder is common in people with MS. As the disease worsens, it is associated with impaired balance, difficulty walking, decreased mobility, and an increased risk of falling. Given the preval...
Detailed Description
Multiple sclerosis (MS) is a progressive disease of the central nervous system characterized by demyelination and destruction of motor and sensory axons. As the disease worsens, it is associated with ...
Eligibility Criteria
Inclusion
- Having an EDSS score of 4 and below,
- Being between the ages of 18-65
- Willingness to participate in the study
Exclusion
- Being pregnant or within the first 3 months after giving birth,
- Receiving corticosteroid therapy in the last 1 month,
- Using drugs that will affect walking in the last 1 month
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 6 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05433714
Start Date
August 1 2022
End Date
October 6 2022
Last Update
October 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kahramanmaraş Sutcu Imam University
Kahramanmaraş, Turkey (Türkiye)